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Abstract Oxidative stress is a common feature in most hepatopathies. Accumulating
evidences indicate that reactive oxygen species (ROS) induce a number
of functional changes either deleterious or adaptive in the capability of
the hepatocytes to produce bile and to secrete exogenous and endogenous
compounds. This review is aimed to describe the mechanisms involved in these
changes. For this purpose, we will summarize:
1. The current evidence that acutely induced oxidative stress is cholestatic,
by describing the mechanisms underlying the hepatocyte secretory failure,
including the disorganization of the actin cytoskeleton and its most
noticeable consequences, that is, the impairment of tight-junctional
structures and the endocytic internalization of canalicular transporters
relevant to bile formation.
2. The role for oxidative-stress-activated signalling pathways in the
pathomechanisms described above, particularly those involving Ca
2+
elevation and its consequent activation via Ca
2+
 of “classical” and “novel”
PKC isoforms.
3. The mechanisms involved in the adaptive response against oxidative stress
mediated by ROS-responsive transcription factors, such as upregulation
of GSH synthesis pathway, antioxidant enzymes, and hepatocellular efflux
pumps.
4. The consequences on hepatocellular secretory function when this adaptive
response can be surpassed by the sustained/high production of ROS. This
deleterious effects include transcriptional and posttranscriptional changes
in the expression of transporters relevant to bile formation, as has been
shown to occur, for example, after long-term administration of aluminum
to rats, in the Long-Evans Cinnamon rat (a model of chronic hepatic copper
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16 Abstract
17 Oxidative stress is a common feature in most hepatopathies. Accumulating
18 evidences indicate that reactive oxygen species (ROS) induce a number of
19 functional changes either deleterious or adaptive in the capability of the hepa-
20 tocytes to produce bile and to secrete exogenous and endogenous compounds.
21 This review is aimed to describe the mechanisms involved in these changes. For
22 this purpose, we will summarize:
23 1. The current evidence that acutely induced oxidative stress is cholestatic, by
24 describing the mechanisms underlying the hepatocyte secretory failure, including
25 the disorganization of the actin cytoskeleton and its most noticeable conse-
26 quences, that is, the impairment of tight-junctional structures and the endocytic
27 internalization of canalicular transporters relevant to bile formation.
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(CONICET – U.N.R.), Rosario, Argentina
e-mail: mroma@fbioyf.unr.edu.ar
I. Laher (ed.), Systems Biology of Free Radicals and Anti-Oxidants,
DOI 10.1007/978-3-642-30018-9_140, # Springer-Verlag Berlin Heidelberg 2014
1
Comp. by: Udayasankar Stage: Proof Chapter No.: 140 Title Name: HBOS
Date:9/3/13 Time:06:15:06 Page Number: 2
28 2. The role for oxidative-stress-activated signalling pathways in the
29 pathomechanisms described above, particularly those involving Ca2+ elevation
30 and its consequent activation via Ca2+ of “classical” and “novel” PKC isoforms.
31 3. The mechanisms involved in the adaptive response against oxidative stress
32 mediated by ROS-responsive transcription factors, such as upregulation of
33 GSH synthesis pathway, antioxidant enzymes, and hepatocellular efflux pumps.
34 4. The consequences on hepatocellular secretory function when this adaptive
35 response can be surpassed by the sustained/high production of ROS. This
36 deleterious effects include transcriptional and posttranscriptional changes in
37 the expression of transporters relevant to bile formation, as has been shown to
38 occur, for example, after long-term administration of aluminum to rats, in the
39 Long-Evans Cinnamon rat (a model of chronic hepatic copper accumulation
40 mimicking Wilson’s disease), and in ischemia-reperfusion injury.
41 Keywords
42 Actin • Bile secretion • Calcium • Cholestasis • Oxidative stress • Protein kinases
43 • Signalling • Tight junctions
445 Introduction
46 Due Au1to its multiple energy-dependent functions, liver has a high mitochondrial
47 metabolic rate and is heavily engaged in detoxification mechanisms that involve
48 redox-enzyme systems. Since these are major sources of endogenous radical oxy-
49 gen species (ROS), production of these highly reactive, cytotoxic compounds is
50 higher in liver as compared with most organs. Au2Hence, hepatocytes are rich in
51 antioxidant defenses to counterbalance this oxidative challenge (Cesaratto et al.
52 2004). However, this borderline equilibrium makes liver highly susceptible to the
53 pro-oxidant injury induced by pathological conditions (Kaplowitz and Tsukamoto
54 1996). Oxidative stress (OS) is a common feature in most hepatopathies including
55 hepatic ischemia-reperfusion injury following hepatectomy or liver transplantation
56 (Czubkowski et al. 2011; Galaris et al. 2006); obstructive cholestasis (Vendemiale
57 et al. 2002); chronic cholestatic liver diseases (Copple et al. 2010; Salunga et al.
58 2007); sepsis-induced cholestasis (Sakaguchi and Furusawa 2006); viral (Simula
59 and De V 2010), toxic (Stehbens 2003), and autoimmune (Pemberton et al. 2004)
60 hepatitis; alcoholic (Wu and Cederbaum 2009) and nonalcoholic (Koek et al. 2011)
61 steatohepatitis; and pathologies leading to hepatic accumulation of heavy metals,
62 such as iron (hemochromatosis, iron-loading anemia) (Alla and Bonkovsky 2005)
63 or copper (Wilson’s disease) (Dalgic et al. 2005).
64 In recent years, evidence has accumulated that OS is cholestatic. Functional
65 changes involve impairment of biliary secretion through both direct oxidative
66 damage of cellular structures involved in this process or, more significantly, via
67 modification of intracellular signal transduction pathways sensitive to changes in
68 the intracellular redox state. We will summarize here the mechanisms involved in
69 these alterations.
2 C.L. Basiglio et al.
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701 Normal Mechanisms of Bile Formation
72 Bile formation is an osmotic process driven by the vectorial transport of certain
73 osmotic solutes into bile, mainly bile salts and both oxidized (GSSG) and reduced
74 (GSH) glutathione (see Fig. 140.1). For these solutes to drive blood-to-bile water
75 transport, they need to be concentrated and retained into a confined space (the bile
76 canaliculus), sealed by tight-junctional structures localized in the paracellular
77 pathways. Once secreted, these solutes induce osmotic water movement, mainly
78 through aquaporins type 9 and 8, located at the basolateral and apical membranes,
79 respectively (Marinelli et al. 2011).
Fig. 140.1 Main transport systems and metabolic events involved in bile flow formation and the
hepatic handling of the endogenous and exogenous cholephilic organic anions bilirubin and
sulfobromophthalein (BSP), respectively. For details, see section “Normal Mechanisms of Bile
Formation”
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80 This primary (canalicular) secretion is further modified by cholangiocytes dur-
81 ing its transit along bile ducts, as a result of a balance between hormone-dependent
82 water and electrolyte secretion and, on the other hand, the obligatory absorption
83 of water, electrolytes and organic solutes (Elsing et al. 1996; Marinelli and
84 LaRusso 1996).
85 Bile salts are the predominant organic solutes in bile. The main sinusoidal
86 transport system for bile-salt uptake is the Na+-taurocholate cotransporting poly-
87 peptide, which has been cloned from both rat (Ntcp, Slc10a1) (Hagenbuch et al.
88 1991) and human liver (NTCP, SLC10A1) (Hagenbuch and Meier 1994). Ntcp/
89 NTCP is driven by a transmembrane Na+ gradient maintained by the Na+/K+-
90 ATPase pump, which is also localized in the sinusoidal membrane (Bohan and
91 Boyer 2002). Ntcp/NTCP accounts for the transport of more than 80 % of amidated
92 bile salts (the major circulating bile salts) and only 40 % of their unconjugated,
93 parent compounds (Kouzuki et al. 1998). The remaining fraction of circulating bile
94 salts is taken up by a non-electrogenic, Na+-independent transport system, formed
95 by a family of transporters collectively named organic anion-transporting poly-
96 peptides (Oatps/OATPs for rat and human, respectively) (Kullak-Ublick et al.
97 2000). Apart from bile salts, Oatps/OATPs accept a wide range of amphipathic,
98 organic compounds, including bilirubin, bilirubin glucuronides, leukotrienes,
99 estrogens, “type II” organic cations, and several exogenous organic anions, the
100 cholephilic dye sulfobromophthalein (BSP) being a prototypical example of the
101 latter one (Hagenbuch and Meier 2003).
102 After traversing the cell by Fick’s diffusion bound to high-affinity cytosolic pro-
103 teins, monoanionic bile salts (C24 amides conjugated with glycine or taurine) are
104 excreted in the canalicular pole by the bile-salt export pump (BSEP/Bsep; ABCB11/
105 Abcb11), an ATP-binding cassette transporter (Suchy and Ananthanarayanan 2006).
106 In contrast, canalicular efflux of divalent, bipolar sulfated or glucuronidated bile salts
107 is mediated by the multidrug resistance-associated protein 2 (MRP2/Mrp2; ABCC2/
108 Abcc2). This carrier also transfers endogenous and exogenous non-bile-acid
109 organic anions conjugated with glutathione and glucuronic acid, including bilirubin
110 glucuronides and BSP both in its unconjugated and conjugated forms (Nies and
111 Keppler 2007).
112 The bile-salt-independent fraction of the bile flow depends on glutathione
113 excretion, mainly in its reduced form (80 %) (Ballatori and Truong 1992).
114 Hepatocellular glutathione transport is poorly understood. The liver is the main
115 site of glutathione synthesis, through a pathway involving two consecutive steps,
116 catalyzed by the enzymes g-glutamyl-cysteinyl synthetase (g-GCS) and glutathione
117 synthetase (GS). The tripeptide is then exported into both blood and bile, and all
118 biliary glutathione comes from this intracellular source (Garcia-Ruiz et al. 1992).
119 However, a high-affinity, electrogenic carrier has been functionally characterized,
120 but not cloned as yet (Ballatori and Dutczak 1994), which exports actively GSH
121 into bile, and can transfer with low-affinity GSSG and GSH conjugates as well.
122 Another transporter likely involved in glutathione canalicular transport is Mrp2.
123 However, this carrier bears low affinity towards GSH, although it can transfer
124 GSSG and GSH conjugates with high affinity (Yang and Hill 2001).
4 C.L. Basiglio et al.
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125 Canalicular bile flow is further modified during its transit along bile ducts by
126 both secretory and absorptive processes (Bogert and LaRusso 2007). Ductular fluid
127 secretion is mainly driven by the secretin-regulated, cAMP-dependent output of
128 a HCO3
-rich fluid secreted via the Cl/HCO3
-exchange system, anion
129 exchanger 2 (Ae2/AE2). Exchange is dependent on the out-to-in Cl-concentration
130 gradient, which is maintained by the Cl efflux across the apical membrane via the
131 ATP-dependent, secretin-activated, cystic fibrosis transmembrane regulator
132 (CFTR). Blood-to-bile water movement at the ductular level is facilitated by
133 constitutive AQP4 in the basolateral membrane and secretin-stimulated AQP1 in
134 the apical membrane (Marinelli et al. 2011). On the other hand, absorption of
135 ductular water and electrolytes is driven by the osmotic gradients created by bile-
136 to-plasma transport of electrolytes and organic solutes. They comprise (i) gluta-
137 mate, transported by as yet unidentified carriers; (ii) glucose, transported by SGLT1
138 and GLUT1 at the apical and basolateral domains, respectively; and (iii) bile salts,
139 taken up by the apical Na+-dependent bile-salt transporter, ASBT/Asbt (SLC10A2/
140 slc10a2), and extruded by both the basolateral export pump, MRP3/Mrp3 (ABCC3/
141 Abcc3), and the heterodimeric organic solute transporter, OSTa-OSTß/Osta-Ostß
142 (Marinelli and LaRusso 1996; Xia et al. 2006).
1434 Changes in Hepatobiliary Secretory Function Induced by OS
145 Compelling evidence in the literature indicates that oxidative challenge affects the
146 hepatocyte secretory machinery by impairing both bile flow (hepatocellular chole-
147 stasis) and the biliary excretion of both endo- and xenobiotics.
148 OS-induced impairment of bile flow generation has been demonstrated to occur
149 soon after exposure to a number of pro-oxidant agents, including tert-
150 butylhydroperoxide (tBOOH) (Ballatori and Truong 1989; Schmitt et al. 2000),
151 hydrogen peroxide (Akerboom et al. 1984; Ballatori and Truong 1989), menadione
152 (te Koppele et al. 1991), allyl alcohol (te Koppele et al. 1991), ethylhexanol
153 (te Koppele et al. 1991), chloro-dinitrobenzene (Schmitt et al. 2000), CCl4 (Eipel
154 et al. 2007), ethacrynic acid (Ji et al. 2004), and lindane (Barros et al. 1988), among
155 others. Some pharmacological agents, such as cyclosporine A (Bramow et al.
156 2001), dapsone (Veggi et al. 2002, 2005), and nitrofuran derivatives (Hoener
157 1988), also induce cholestasis due, at least in part, to their pro-oxidant properties.
158 Finally, maneuvers leading to hepatic OS, such as hepatic (Accatino et al. 2003;
159 Bowers et al. 1987; Lee et al. 2000) and intestinal (Turnage et al. 1991) ischemia-
160 reperfusion or aluminum intoxication (Gonzalez et al. 2004, 2007), also induce bile
161 flow impairment.
162 The classical view to interpret the cholestasis associated to pro-oxidant condi-
163 tions is based upon the following pathomechanisms:
164 i. Reduction of the number of living parenchymal liver cells by necrosis and
165 apoptosis depending on the severity of the oxidative injury (Czaja 2007).
166 ii. Impairment of the bile-salt-dependent fraction of the bile flow due to compet-
167 itive inhibition of bile-salt transport by the intracellular GSSG formed in excess
140 Radical Oxygen Species and Bile Secretion 5
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168 during the oxidative challenge (Akerboom et al. 1984; Ballatori and Truong
169 1989). Indeed, GSSG cis-inhibits the transport bile salts in liver canalicular
170 membrane vesicles (Griffiths et al. 1987), and mirror curves showing an inverse
171 relationship between GSSG and bile-salt biliary excretions have been obtained
172 when different pro-oxidizing compounds were administered in the isolated rat
173 perfused liver, such as hydrogen peroxide (Akerboom et al. 1984), menadione
174 (Akerboom et al. 1988), and tBOOH (Akerboom et al. 1984; Ballatori and
175 Truong 1989).
176 iii. Impairment of the bile-salt-independent bile flow due to a decrease in the biliary
177 excretion of total glutathione (GSH plus GSSG). This occurs due to depletion of
178 the hepatic levels of glutathione due to the sustained plasmatic and biliary
179 exportation from the cell as GSSG to maintain the GSH/GSSG ratio (Koeppel
180 et al. 1998).
181 The above-mentioned mechanisms may be predominant under strong oxidizing
182 conditions. However, under mild or even low oxidizing conditions, bile secretory
183 failure still occurs. For example, upon administration of different pro-oxidant
184 compounds to isolated perfused rat livers, drop in bile flow and/or decrease in
185 bile-salt secretion occurs before leakage of cytosolic hepatocellular enzymes or
186 increments in intracellular GSSG become apparent (Ballatori and Truong 1989; Ji
187 et al. 2004). Likewise, in isolated rat hepatocyte couplets, the apical secretion of
188 fluorescent bile-salt analogues was impaired by low concentrations of the pro-
189 oxidant compounds tBOOH and 2,3-dimethoxy-1,4-naphthoquinone, even when
190 cell viability and intracellular GSSG levels remained unaffected (Pérez et al.
191 2006a). Overall, these results suggest that more subtle changes in the machinery
192 involved in bile formation occur under mild OS conditions. Among them, the actin-
193 cytoskeletal disruption, which occurs even at very low OS levels, seems to be
194 a crucial causal factor, as discussed next.
195 Cytoskeletal Integrity and Hepatocanalicular Function
196 The actin cytoskeleton is a dynamic network of filamentous actin (F-actin), formed
197 by the reversible assembly of monomeric actin (G-actin), spatially distributed as
198 a belt around the bile canaliculus.
199 Actin cytoskeleton is one of the primary targets of ROS. The oxidative challenge
200 promotes the oxidation of actin at a sulfhydryl group of a cysteine in position 374
201 (Dalle-Donne et al. 2001). This induces conspicuous changes in actin-spatial
202 distribution, resulting in marked changes in the cellular topology (plasma mem-
203 brane blebbing) (Dalle-Donne et al. 2001; Mirabelli et al. 1988).
204 Most of the above-mentioned roles of actin in cellular biology apply to hepato-
205 cytes, and many of them are involved in the biliary secretory processes. It is
206 therefore not surprising that disorganization of the actin cytoskeleton induced by
207 ROS has several deleterious effects on hepatobiliary function.
208 The interrelationship between ROS, Ca2+ elevations, actin-cytoskeletal integ-
209 rity, and hepatocanalicular secretory function was exhaustively investigated in the
6 C.L. Basiglio et al.
Comp. by: Udayasankar Stage: Proof Chapter No.: 140 Title Name: HBOS
Date:9/3/13 Time:06:15:18 Page Number: 7
210 1990s by our group, using the hepatocyte couplet model. These studies revealed
211 that, under mild OS conditions with preserved hepatocellular viability,
212 a close relationship exists between the disarrangement of the pericanalicular actin
213 cytoskeleton and the impairment in the capability of the couplets to accumulate
214 apically and retain in their canalicular vacuoles fluorescent bile-salt analogues
215 induced by the oxidizing compounds tBOOH (Ahmed-Choudhury et al. 1998;
216 Pérez et al. 2006a, b; Roma et al. 1997) and menadione (Stone et al. 1994, 1996).
217 These two independent tests indicated that both the apical secretion of bile salts and
218 their further tight-junctional-dependent retention in the bile canaliculus are impaired
219 early under OS conditions. Impairment of tight-junctional permeability was
220 also observed in isolated perfused rat livers exposed to tBOOH (Ballatori and
221 Truong 1989).
222 These functional alterations to secrete and retain bile salts in the biliary space
223 seem to have a structural correlate. tBOOH induces disorganization of the tight-
224 junctional complex in hepatocyte couplets, as suggested by the redistribution of the
225 tight-junctional-associated protein, ZO-1 (Pérez et al. 2006a); F-actin is anchored to
226 zonula occludens-associated proteins thus regulating paracellular permeability
227 (Anderson and Van Itallie 1995). In addition, the canalicular bile-salt transporter
228 Bsep suffers endocytic internalization into intracellular vesicles in hepatocyte
229 couplets (Pérez et al. 2006b), which reduces dramatically the density of transporters
230 properly located at the membrane domain. A similar phenomenon has been
231 described for the canalicular transporter Mrp2, which suffered endocytic internali-
232 zation after exposure of isolated perfused rat livers to pro-oxidant insult, such as
233 exposure to tBOOH (Schmitt et al. 2000), chloro-dinitrobenzene (Schmitt et al.
234 2000), ethacrynic acid (Ji et al. 2004; Sekine et al. 2006), and lipopolysaccharide
235 (LPS) (Sekine et al. 2010), or after hepatic ischemia-reperfusion (Yu et al. 2007).
236 Mrp2 relocalization has a clear-cut functional correlate. Experiments in isolated
237 perfused rat livers indicated that a high, sustained exposure to ethacrynic acid has an
238 inhibitory effect on the excretion of both unchanged and conjugated forms of the
239 model cholephilic dye and Mrp2 substrate BSP (James and Ahokas 1992). Mrp2
240 relocalization under OS conditions is reversible in nature. When the OS induced by
241 tBOOH in isolated perfused rat livers was reverted by replenishment of GSH with
242 the cell-permeable form, GSH-ethyl ester internalized Mrp2 was relocalized back to
243 the canalicular membrane in a microtubule-dependent manner (Sekine et al. 2008).
244 The exact mechanisms that link OS-induced actin disorganization with tight-
245 junctional impairment and transporter internalization are unknown, but previous
246 studies in the literature provide some clues. Hepatic tight-junctional permeability
247 increases following administration of the actin-disrupting agent phalloidin (Elias
248 et al. 1980). F-actin is anchored to tight-junctional-associated proteins (e.g., ZO-1),
249 and it is likely that F-actin disorganization induces relocalization of zonula
250 occludens intermediary proteins or even proteins forming the tight-junctional
251 strands, such as occludin and claudin.
252 Phalloidin-induced F-actin disorganization also induces internalization of cana-
253 licular transporters, such as Mrp2 (Rost et al. 1999). The retrieval of canalicular
254 transporters under OS conditions (Ji et al. 2004; Pérez et al. 2006b; Schmitt et al.
140 Radical Oxygen Species and Bile Secretion 7
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255 2000; Sekine et al. 2006) is therefore also likely due to the simultaneous F-actin
256 disarrangement. The molecular bases to understand this causal relationship are just
257 emerging. Mice lacking radixin, which cross-links actin filaments and plasma
258 membrane proteins, develop conjugated hyperbilirubinemia associated to retrieval
259 of Mrp2 (Kocher et al. 1999), and the same holds true for obstructive and estrogen-
260 induced cholestasis, where a disturbed colocalization of Mrp2 and radixin is
261 associated with Mrp2 endocytic internalization ( Au3Kojima et al. 2008). Interestingly,
262 the internalization of Mrp2 that occurs after hepatic ischemia-reperfusión is coin-
263 cident with a virtual loss of radixin expression (Shu et al. 2007), and ROS-mediated
264 dephosphorylation and relocalization of radixin has been proposed to account for
265 LPS-induced Mrp2 internalization (Saeki et al. 2011). This latter phenomenon has
266 been associated with the OS induced by this cytokine (Sekine et al. 2010) and seems
267 to involve a decrease in the total amount of the active, phosphorylated form radixin
268 and its degree of interaction with Mrp2 (Saeki et al. 2011).
269 Mediation of Signal Transduction Pathways in OS-Induced Acute
270 Hepatocanalicular Dysfunction
271 Cytosolic Ca2+ elevations occur under OS conditions, due to both the entry of
272 extracellular Ca2+ via plasma membrane receptor-operated Ca2+ channels and the
273 release of Ca2+ from intracellular Ca2+ storages, particularly in the endoplasmic-
274 reticulum (calciosome) (Reed 1990). Ca2+ elevations are a major determinant of the
275 impairment in bile secretion following the oxidative injury. The intracellular Ca2+
276 chelator BAPTA/AM fully prevents the impairment induced by low levels of tBOOH
277 in the capability of the hepatocyte couplets to accumulate and retain in their cana-
278 licular vacuoles bile-salt-fluorescent analogues (Stone et al. 1994). Suggestively, the
279 associated actin-cytoskeletal disarrangement is also prevented by BAPTA/AM,
280 further supporting a causal relationship between both phenomena. Furthermore,
281 Ca2+-elevating agents, such as the Ca2+ ionophore A23187 (Stone et al. 1994) or
282 the inhibitor of endoplasmic-reticulum Ca2+-ATPase thapsigargin (Ballatori and
283 Truong 1989), mimic the deleterious effects of ROS on both actin-cytoskeleton
284 integrity and hepatocanalicular function.
285 A number of signal pathways downstream of Ca2+ are involved in this phenom-
286 enon. Activation of Ca2+-dependent, “classical” protein kinase C isoforms (cPKCs)
287 seems to be one of the most important ones. Our group demonstrated that the
288 pro-oxidant agent tBOOH induces cytosolic-Ca2+ elevations and translocation of
289 the cPKC isoform, PKCa, from the cytosol to the plasma membrane in isolated
290 hepatocytes, even at concentrations low enough to only affect the biliary secretory
291 machinery (Pérez et al. 2006a). Furthermore, several previous findings showed
292 strong similarities between the effect of ROS and those induced by Ca2+ and PKC
293 agonists, namely: (i) Both cytosolic Ca2+ elevations (Nathanson et al. 1992a) and
294 PKC activation (Corasanti et al. 1989) impair bile flow generation in the isolated
295 perfused rat liver (Corasanti et al. 1989), in part by increasing paracellular perme-
296 ability (Kan and Coleman 1988; Llopis et al. 1991); we and others further
8 C.L. Basiglio et al.
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297 characterized these effects in the hepatocyte couplet model and showed that cyto-
298 solic Ca2+ elevations impair the couplet capability to secrete and retain in their
299 canalicular vacuoles fluorescent bile-salt analogues by activating cPKC (Roma et al.
300 1999) and that PKC activation by vasopressin and phorbol esters reproduced these
301 effects (Nathanson et al. 1992b; Roma et al. 1997, 1998). (ii) PKC agonists induce
302 F-actin-cytoskeletal disarrangements (Roma et al. 1998), and Ca2+-elevating agents
303 reproduced these effects by a PKC-dependent mechanism (Roma et al. 1999).
304 Final confirmation of a crucial role for cPKC activation in actin disorganization
305 and hepatocanalicular dysfunction induced by ROS was provided by recent studies
306 in hepatocyte couplets. ROS-mediated actin-cytoskeleton disarrangements were
307 fully prevented by both PKC-pan-specific and cPKC-specific inhibitors (Pérez
308 et al. 2006a). More relevant from the therapeutic point of view, both cytoskeleton
309 disruption and canalicular dysfunction were reversed within 1 h by these inhibitors
310 (Pérez et al. 2006a).
311 The retrieval of the bile-salt transporter Bsep from the canalicular membrane
312 was also fully prevented by PKC antagonists (Pérez et al. 2006b). The same holds
313 true for the impairment of the tight-junctional-retentive properties, another possible
314 consequence of the actin disassembly induced by exposure to pro-oxidant
315 agents (Pérez et al. 2006a). The mechanisms that explain the harmful effect
316 of PKC on actin integrity and, by extension, on the hepatocanalicular function as
317 a whole remain unclear. PKC phosphorylates and/or disorganizes several
318 actin-cytoskeletal components, including actin itself, actin-associated proteins,
319 and membrane-cytoskeletal cross-linked proteins (Keenan and Kelleher 1998;
320 Larsson 2006).
321 The kind of canalicular protein that is internalized under oxidative-stress con-
322 ditions and the signalling molecule involved seem to depend on the pro-oxidant
323 agent employed and on the magnitude of the oxidative damage. Low concentrations
324 of the oxidizing compound, ethacrynic acid, do not translocate cPKC but “novel”
325 PKC isoforms (nPKC). Under these conditions, Mrp2 but not Bsep is internalized,
326 by a mechanism probably involving Ca2+-dependent activation of inducible nitric
327 oxide (NO) synthase (iNOS), followed by NO-mediated cGMP increase and further
328 cGMP-activated nPKC (Sekine et al. 2006). However, higher ethacrynic acid doses,
329 capable of activating cPKC isoforms as well, induce internalization of both Bsep
330 and Mrp2 (Sekine et al. 2006).
331 As summarized in Fig. 140.2, a picture is emerging on the effect of acutely
332 induced OS on the hepatobiliary function. Under mild ROS challenge not affecting
333 hepatocellular viability, Ca2+ elevations induce cPKC and/or nPKC activation. This
334 brings on a number of alterations in both function and localization of structures
335 relevant to bile formation, such as actin cytoskeleton, canalicular transporters, and
336 tight-junctional components. This impairs, in turn, the biliary secretion and the
337 further retention of solutes that provide osmotic driving force for bile formation.
338 Other factors such as GSSG-induced cis-inhibition of bile-salt transport, reduced
339 biliary excretion of glutathione due to intracellular glutathione depletion, and
340 hepatocellular death may become contributing factors, depending on the magnitude
341 of the pro-oxidant condition.
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3423 The Antioxidant Adaptive Hepatic Response and Bile Secretion
344 Hepatocytes develop an adaptive response against ROS when the oxidative insult is
345 sustained (Fig. 140.3). This response involves induction of antioxidant enzymes
346 such as catalase (Sen et al. 2005) and manganese superoxide dismutase (Kwak et al.
347 2001), as well as increments of glutathione synthesis via induction of g-glutamyl-
348 cysteinyl synthetase (Yamane et al. 1998). In addition, hepatic adaptation integrates
349 the distinctive metabolizing and secretory capacity of the organ to reinforce these
350 antioxidant mechanisms. Au4In this context, it is crucial the OS-mediated induction of
351 the phase-II-detoxifying enzymes glutathione-S-transferase (GST) (Kohle and
352 Bock 2007) and UDP-glucuronosyltransferase (UGT) (Kwak et al. 2001).
353 GST induction enhances the coordinated inactivation, via GSH conjugation, of
354 DNA hydroperoxides and lipid hydroperoxides formed as secondary metabolites
355 during OS (Ketterer and Meyer 1989). GST also catalyzes GSH conjugation of
356 highly reactive, toxic a,ß-unsaturated lipid aldehydes, 4-hydroxy trans-2-nonenal
Fig. 140.2 Effect of the model oxidizing compound tert-buthylhydroperoxyde (tBOOH) on the
canalicular transport of bile salts via Bsep and of oxidized glutathione (GSSG) via Mrp2. In
normal cells, the pericanalicular localization of F-actin allows for the normal localization of the
canalicular transporters in their membrane domain and the proper barrier function of the tight-
junctional structures. The acute exposure to tBOOH induces mobilization of Ca2+ across the
plasma and from the calciosome membranes and the further activation of Ca2+-dependent,
“classical” PKC isoforms (cPKC). This activation leads to relocalization of F-actin to the cell
body, which in turn induces blebbing, Bsep/Mrp2 internalization, and tight-junctional disorgani-
zation; these two latter events explain the impairment of bile-salt (BS) and GSSG biliary excretion
and their further canalicular retention. Cytosolic Ca2+ elevations may also activate inducible nitric
oxide (NO) synthase (iNOS), which leads to NO-mediated activation of guanylate cyclase (GC)
and further cyclic guanosine monophosphate (cGMP)-mediated activation of “novel” PKC
isoforms (nPKC); nPKC activation internalizes selectively Mrp2
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357 (HNE) being the most abundant (Renes et al. 2000). These lipid peroxides combine
358 spontaneously with cysteine, histidine, and lysine residues of proteins, which
359 modifies protein function and leads eventually to cellular toxicity.
360 UDP-glucuronosyltransferase induction improves glucuronidation of pro-
361 oxidant toxicants, such as benzo(a)pyrene (Byczkowski and Gessner 1987), penta-
362 chlorophenol (Umemura et al. 2006), acetaminophen (Clement andWilliams 2005),
363 aliphatic alcohols (Ebner and Burchell 1993), and manadione (Liu et al. 1993).
364 These phase-II products are then extruded from the cell via the hepatocellular efflux
365 pumps MRP1, MRP2, MRP3, and MRP4 (ABCC4) and breast cancer resistance
366 protein (BCRP, ABCG2), all of which are also upregulated by ROS (Adachi et al.
367 2007; Au5Aleksunes et al. 2008; Vollrath et al. 2006). Glutathione conjugates are
368 substrates of MRP2 and MRP1 (Geier et al. 2007). Since these transporters also
369 transfer GSSG, MRP1/2-mediated GSSG extrusion helps to maintain low
Fig. 140.3 Main hepatocellular adaptive changes induced by sustained OS in the expression of
enzymes, and transporters involved in: (i) glutathione (GSH) synthesis via g-glutamylcysteine
synthetase (g-GCS) and GSH synthetase (GS), (ii) GSH conjugation of lipid peroxides or their
aldehydic derivatives (LP) via GSH S-transferase (GST), and (iii) plasmatic and biliary extrusion
of conjugated LP and oxidized glutathione (GSSG) via both Mrp1 and Mrp2, respectively. This
adaptive response in mainly governed by the redox-sensitive transcription factor Nrf2, which
escapes from its cytosolic repressor Keap1 and translocates to the nucleus under OS conditions.
Once in there, it binds to the antioxidant response element (ARE) and activates ARE-dependent
gene transcription, including that of g-GCS, GST and Mrp2; Mrp1 activation is instead indepen-
dent on Nrf2. The effect of Nrf2 on g-GCS is reinforced by the activation of the transcription factor
AP-1, via a proximal AP-1 element (PAP-1E). For further details, see section “The Antioxidant
Adaptive Hepatic Response and Bile Secretion”
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370 intracellular GSSG levels, when GSSG reduction back to GSH via GSSG reductase
371 becomes rate limiting. Unlike MRP1, the basolateral carriers MRP3, MRP4, and
372 BCRP transport glucuro- and sulfoconjugates and bile salts (Geier et al. 2007).
373 MRP1, MRP3, and MRP4 are normally expressed at very low levels in
374 the basolateral membrane of the hepatocytes. Upregulation of basolateral extrusion
375 pumps during a sustained oxidant insult is expected to shift the transfer of substrates
376 normally excreted into bile towards blood, to permit urinary excretion. As
377 an untoward effect of this adaptive response, this phenomenon might decrease the
378 biliary excretion of bile salts, which would contribute to the cholestatic
379 phenomenon.
380 All these adaptive mechanisms are transcriptional in nature and involve the
381 activation of a number of redox-sensitive transcription factors, such as Nrf2,
382 NF-kB, and AP-1. The transcription factor activated depends on the magnitude of
383 the oxidant insult. Low OS induces Nrf2, whereas higher levels trigger an
384 inflammatory response through the activation of NF-kB and AP-1 (Halliwell and
385 Gutteridge 1999).
386 Nrf2 is a key transcription factor of the hepatic adaptation to sustained OS. Its
387 induction has been linked to different oxidant agents such as the cancer
388 chemoprotective agent 3H-1,2-dimethiole-3-thione (Kwak et al. 2001), alcohol
389 (Gong and Cederbaum 2006), tert-butylhydroquinone (Adachi et al. 2007), acet-
390 aminophen (Aleksunes et al. 2008), and bile salts (Tan et al. 2007). The action of
391 Nrf2 depends on its accumulation in the nucleus, where it interacts with the
392 antioxidant response element (ARE) (Nguyen et al. 2003). This is a cis-acting
393 enhancer sequence that contains the 50-TGAC-30 tetranucleotide present in the
394 genes of enzymes associated with glutathione biosynthesis, redox proteins with
395 active sulfhydryl moieties, drug-metabolizing enzymes, and transporters. Nrf2
396 induces the transcription of g-glutamylcysteine synthetase, the rate-limiting enzyme
397 responsible for glutathione synthesis (Kwak et al. 2001). The effect of Nrf2 on this
398 enzyme is reinforced by AP-1. A proximal AP-1 element (263 to 269) has been
399 identified to be critical in mediating the effect of OS-induced increase in the
400 transcription of the human catalytic subunit of this enzyme (Rahman et al. 1996).
401 Nrf2 also induces GST and UDP-glucuronosyltransferase (Kohle and Bock 2007;
402 Kwak et al. 2001; Yueh and Tukey 2007), as well as the hepatocellular transporters
403 MRP2 (Vollrath et al. 2006), MRP3 (Aleksunes et al. 2008), MRP4 (Aleksunes et al.
404 2008), and BCRP (Adachi et al. 2007). Nrf2-induced coordinated GST and Mrp2
405 expression increases the biliary excretion of conjugated BSP and possibly other
406 glutathione-conjugated compounds, such as DNA and lipid hydroperoxides
407 (Reisman et al. 2009). Furthermore, Nrf2 constitutes a defense system against
408 oxidative stress generated in the liver by experimental models of both extrahepatic
409 (Okada et al. 2009) and intrahepatic (Tanaka et al. 2009) cholestasis. Finally, Nrf2 is
410 required for the upregulation of basolateral bile-salt efflux pumps that counteract the
411 deleterious effects of hepatocellular build up of bile salts in cholestasis, as part of the
412 adaptive response against this condition (Tanaka et al. 2009).
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4134 Impairment of Hepatobiliary Function Induced by Sustained OS
415 The adaptive, spontaneous mechanisms that take place in hepatocytes to minimize
416 the deleterious effects of ROS are, however, not always sufficient to prevent
417 hepatocellular oxidative damage. When ROS production is maintained with time
418 at high levels, alterations occurs in the capability of the hepatocyte to produce bile
419 and to secrete cholephilic compounds, mainly because of changes in the expression
420 of transporters.
421 The Long-Evans Cinnamon rat, an animal model of Wilson’s disease, is
422 a prototypical model of high, chronic hepatic OS. These rats have a genetic defect
423 in Atp7b gene, which is homologous to the human Wilson’s disease gene, resulting
424 in inability to mobilize copper from the liver (Harada et al. 2000). Apart from
425 copper, these rats also have high hepatic iron levels (Kato et al. 1993). Chronic
426 copper/iron accumulation increases lipid peroxidation by 50 %, presumably due to
427 the capability of these metals to induce OS via both mitochondrial dysfunction
428 (Sternlieb et al. 1995) and Fenton-type, copper/iron-catalyzed Haber-Weiss reac-
429 tion (Yamamoto et al. 2001).
430 These mutant rats have histological features of cholestasis (Du et al. 2004) and
431 exhibit a number of alterations in hepatic transporter expressions. They have
432 a reduced basal bile-salt biliary excretion due to a posttranscriptional impairment
433 in Bsep expression (Chiba et al. 2007; Levy et al. 2007). On the other hand, mRNA
434 levels of the bile-salt uptake systems Ntcp and Oatp (isoforms Oatp1a1 and
435 Oatp1a4) are decreased, although this has not been confirmed at the protein level
436 (Chiba et al. 2007). Apart from alterations in bile-salt hepatic handling, Long-Evans
437 Cinnamon rats have both hyperbilirubinemia (Du et al. 2004; Yamamoto et al. 2001)
438 and impairment in the excretion of the Mrp2 substrate BSP (Itagaki et al. 2004). Au6If
439 these alterations involve changes in the expression of Mrp2 at a protein level is
440 unknown, but Mrp2 mRNA levels are normal (Chiba et al. 2007). Alternatively, the
441 above-mentioned transcriptional downregulation of Oatps, which also transport
442 non-bile-salt organic anions such as BSP and bilirubin, may be a contributing factor.
443 Another experimental model of metal-induced chronic OS is that afforded by
444 long-term aluminum (Al3+) exposure to rats (Gonzalez et al. 2007). When admin-
445 istered intravenously for 1–2 weeks, Al3+ reduces bile flow, and this impairment
446 correlates directly with Al3+ hepatic content; this was associated with elevations of
447 serum bile salts, suggesting impaired hepatic handling of bile salts (Klein et al.
448 1988). An even more chronic exposure to Al3+ (3 months), which doubles the lipid-
449 peroxidation levels, also reduced bile flow and the biliary output of bile salts
450 (Gonzalez et al. 2004). Compartmental analysis of the plasma decay of BSP
451 revealed that both sinusoidal uptake and canalicular excretion of the dye are
452 decreased, the latter phenomenon being associated with a decrease in Mrp2 protein
453 expression (Gonzalez et al. 2004). All these alterations were prevented by admin-
454 istration of the antioxidant vitamin E, suggesting that OS was the main, if not the
455 only, mechanism (Gonzalez et al. 2007).
140 Radical Oxygen Species and Bile Secretion 13
Comp. by: Udayasankar Stage: Proof Chapter No.: 140 Title Name: HBOS
Date:9/3/13 Time:06:15:28 Page Number: 14
456 Hepatic ischemia-reperfusion injury is another prototypical OS-mediated
457 hepatopathy associated with both cholestasis (Lee et al. 2000; Lemasters and
458 Thurman 1997) and changes in expression of hepatocellular transporters (Tanaka
459 et al. 2006, 2008) (Fig. 140.4).
460 The impact of this maneuver on both bile flow generation and the expression of
461 transporters depends on the duration of the ischemia. A 30-min ischemia decreases
462 both bile flow and biliary bile-salt output after 1 day of reperfusion, but no changes
463 occur in mRNA and protein levels of the main basolateral and canalicular bile-salt
464 transporters, Ntcp and Bsep, respectively (Accatino et al. 2003); in this case,
465 changes in localization/intrinsic activity of these transporters or impairment in the
466 expression of other bile-salt transporters, such as Oatps, may explain bile-salt-
467 secretory failure. Similarly, Mrp2, mRNA, and protein expressions are unaffected,
468 in agreement with the absence of changes in the maximum-secretory rate of
469 the Mrp2 substrate ceftriaxone (Accatino et al. 2003). Unlike a 30-min ischemia,
Fig. 140.4 Changes in the expression of transporters relevant to bile flow generation in hepatic
injury induced by ischemia-reperfusion. An ischemic period of 60 min, followed by 1 day of
reperfusion, decreases the mRNA levels of the basolateral transporters Ntcp and OATP, as well as
the canalicular export pumps Mrp2 and Bsep (only confirmed at the protein level for Mrp2). It is
unknown whether ischemia-reperfusion exerts these transcriptional effects via ROS-induced
changes in degradation/function of RNA polymerase II (RNA Pol II) or, indirectly, by promoting
the release of proinflammatory cytokines, which may both downregulate transcription factors (TF)
that function as transactivators of hepatocellular transporters and reduce their DNA binding
activity. Since downregulation of Mrp2 protein is more severe than that of its mRNA, an additional
posttranscriptional mechanism is proposed, which involves OS-induced transporter internaliza-
tion, followed by lysosomal degradation. For further details, see section “Impairment of
Hepatobiliary Function Induced by Sustained OS”
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470 a 60-min ischemic period followed by 1 day of reperfusion decreases the mRNA
471 levels of the basolateral transporters Ntcp and Oatp (all isoforms), as well as those
472 of the canalicular export transporters, Mrp2 and Bsep (Tanaka et al. 2006); this has
473 been confirmed at the protein level only for Mrp2 (Tanaka et al. 2008).
474 The mechanisms by which these transcriptional alterations occur are far from
475 being understood. First, we have to bear in mind that high levels of OS globally
476 inhibit gene transcription by inducing RNA polymerase II degradative
477 ubiquitination and decrease in histone H3 and H4 acetylation; histone acetylation
478 dissociates DNA from the histone complex, allowing transcription to proceed
479 (Berthiaume et al. 2006). However, at least part of these transcriptional alterations
480 may be due to the ROS-dependent hepatic inflammatory response, which leads to
481 release of cholestatic, proinflammatory cytokines (e.g. TNF-a and IL-1ß) with
482 capability to transcriptionally impair transporter expression (Geier et al. 2007).
483 This phenomenon involves downregulation of the ubiquitous heterodimerization
484 partner retinoid X receptor (RXRa), leading to impairing of the binding activity
485 of nuclear receptor heterodimers that requires RXRa for their transcriptional
486 activity or, in particular, for Ntcp and Mrp2, respectively, and to reduction of the
487 nuclear levels of the monomeric transcription factors hepatocyte nuclear factor-1a
488 (HNF-1a) (Geier et al. 2007) and interferon regulatory factor 3 (IRF3) (Hisaeda
489 et al. 2004).
490 In ischemia-reperfusion injury, downregulation of Mrp2 protein is more pro-
491 found than that of mRNA, suggesting additional posttranscriptional mechanisms
492 (Tanaka et al. 2008). Although the causes underlying the latter phenomenon are
493 presently unknown, the early OS-induced transporter internalization, sustained with
494 time, may lead to delivery of the endocytosed transporters to the lysosomal com-
495 partment, followed by degradation, as was suggested to occur late in LPS-induced
496 cholestasis (Kubitz et al. 1999) and in obstructive cholestasis (Paulusma et al. 2000)
497 in rats, two cholestatic models exhibiting OS. Apart from alterations in transporter
498 expression/function, the tight-junctional barrier is impaired in ischemia-reperfusion
499 injury, as shown in 24- or 48-h-cold-stored isolated perfused rat livers subjected to
500 reperfusion (Almada et al. 2003).
501 Taken together, these models of long-lasting OS show consistently that chole-
502 stasis and/or impairment of the constitutive expression of transporters relevant to
503 bile formation is a common feature in prolonged OS and that both transcriptional
504 and posttranscriptional mechanisms are involved. Proinflammatory cytokines
505 released by the inflammatory response to the oxidative liver damage may be key
506 mediators.
5078 Future Directions
509 Cholestasis is a common feature under OS conditions, even at OS levels far lower
510 than those affecting hepatocellular viability. Despite considerable progresses have
511 been made in the characterization of the effects of ROS on the biliary secretory
512 machinery, the characterization of the molecular mechanisms underlying these
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513 effects is in its infancy. A bridge needs to be built between early events and late
514 consequences of OS on bile secretion, in order to reconstruct the cascade of events
515 leading to the posttranscriptional changes in transporter protein expression
516 observed eventually during the sustained oxidative challenge. Also, we need to
517 distinguish direct ROS-mediated effects from secondary consequences of the oxi-
518 dative injury (e.g., inflammatory response, accumulation of biliary solutes). In
519 addition, we must fully characterize the redox-sensitive signalling pathways
520 involved in these effects; a more complete picture should provide more selective
521 therapeutic strategies to interfere with ROS-mediated harmful pathways or to
522 enhance the protective ones. Studies on the impact of OS on transport function of
523 biliary epithelial cells are also eagerly awaited; cholangiocytes may contribute to
524 bile secretory failure, as they are the main target of cholangiopathies associated with
525 periductal inflammation and OS. And finally, it remains to be ascertained the actual
526 contribution of OS in both transcriptional and posttranscriptional changes in liver
527 transporter expression occurring in chronic cholestatic liver diseases in humans
528 (Geier et al. 2007).
529 Genomic and proteomic tools are accelerating the discovery of new ROS-
530 responsive genes and the molecular targets of ROS action. These approaches are
531 expected to greatly help to achieve the goals above. Meanwhile, we hope this
532 preliminary information contributes to draw attention about the convenience of
533 limiting OS in hepatopathies with cholestatic features. Some short-scale clinical
534 studies using co-adjuvant, antioxidant therapies have shown encouraging results
535 (Vendemiale et al. 2002), but multicentric and long-term clinical trials are needed
536 to determine whether this strategy holds promise for the future.
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